| Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients EP Juliá, P Mandó, MM Rizzo, GR Cueto, F Tsou, R Luca, C Pupareli, ... Cancer Immunology, Immunotherapy 68, 1585-1596, 2019 | 43 | 2019 |
| Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era P Mandó, SG Rivero, MM Rizzo, M Pinkasz, EM Levy The Breast 60, 15-25, 2021 | 40 | 2021 |
| Breast cancer in young women presents with more aggressive pathologic characteristics: Retrospective Analysis From an Argentine National Database V Fabiano, P Mandó, M Rizzo, C Ponce, F Coló, M Loza, J Loza, M Amat, ... JCO global oncology 6, 639-646, 2020 | 37 | 2020 |
| Efficacy and safety of nivolumab in previously treated patients with non–small-cell lung cancer: real world experience in Argentina C Martin, L Lupinacci, F Perazzo, C Bas, O Carranza, C Puparelli, ... Clinical Lung Cancer 21 (5), e380-e387, 2020 | 22 | 2020 |
| High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients P Mandó, M Rizzo, MP Roberti, EP Juliá, MB Pampena, ... OncoTargets and therapy, 2901-2910, 2018 | 19 | 2018 |
| Burnout syndrome in medical oncologists during the COVID-19 pandemic: Argentinian national survey A Guercovich, G Piazzioni, F Waisberg, P Mandó, M Angel ecancermedicalscience 15, 2021 | 13 | 2021 |
| A theoretical view of ovarian cancer relapse GH Giornelli, P Mandó EMJ 2 (3), 128-35, 2017 | 13 | 2017 |
| High histologic grade and high Ki-67 expression predict phenotypic alterations in node metastasis in primary breast cancers P Mandó, M Rizzo, CP De La Puente, M Maino, C Ponce, MT Pombo, ... Journal of Breast Cancer 20 (2), 170-175, 2017 | 12 | 2017 |
| Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review D Enrico, F Waisberg, J Burton, P Mandó, M Chacon Critical Reviews in Oncology/Hematology 160, 103296, 2021 | 9 | 2021 |
| Predictive factors for non-sentinel lymph node metastasis in patients with ACOSOG Z0011 criteria CM Loza, P Mandó, C Ponce, F Coló, V Fabiano, J Loza, MV Costanzo, ... Breast Care 13 (6), 434-438, 2018 | 9 | 2018 |
| HER2-directed therapy in advanced breast cancer: benefits and risks P Mandó, F Waisberg, R Pasquinelli, S Rivero, A Ostinelli, F Perazzo OncoTargets and therapy, 115-132, 2023 | 5 | 2023 |
| Young oncologists’ perspective on the role and future of the clinician-scientist in oncology KHJ Lim, CB Westphalen, AS Berghoff, C Cardone, EA Connolly, ... ESMO open 8 (5), 2023 | 5 | 2023 |
| Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: a systematic review F Waisberg, C Lopez, D Enrico, A Rodriguez, I Hirsch, J Burton, P Mandó, ... Critical Reviews in Oncology/Hematology 176, 103747, 2022 | 4 | 2022 |
| Prevalence of hepatitis E virus in children from Northeast of Argentina AP Martínez, MJ Pereson, PS Pérez, MI Baeck, P Mandó, ... Journal of Medical Virology 93 (6), 4015-4017, 2021 | 4 | 2021 |
| A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A … GM Villoldo, MT Pombo, M Aris, J Chemi, P Mandó, S Nagaraju, ... Oncology Research 31 (2), 207, 2023 | 3 | 2023 |
| Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients MB Bordignon, AI Pesce Viglietti, EP Juliá, MB Sanchez, A Rölle, ... Cancer Immunology, Immunotherapy 72 (8), 2687-2700, 2023 | 2 | 2023 |
| The BA-BCS 2021: an initial “trial” for integrating basic science and medical progress on breast cancer in a Latin-American country E Kordon, C Lanari, P Mando, V Novaro, M Rossi, M Simian Journal of Mammary Gland Biology and Neoplasia, 1-8, 2021 | 2 | 2021 |
| Los linfocitos estromales intratumorales (tils) como factor pronóstico en tumores primarios de mama Triple Negativos M Amat, P Mandó, A Ostinelli, M Rizzo, C Pérez de la Puente, ... Rev. argent. mastología, 69-79, 2018 | 2 | 2018 |
| TDM-1 en cáncer de mama metastásico her2 positivo: Experiencia institucional CA Ostinelli, P Mandó, CP de la Puente, M Rizzo, S Rivero, V Costanzo, ... Oncología Clínica 21 (3), 2016 | 2 | 2016 |
| Prevalence of Chagas Disease and Associated Factors in an Endemic Area of Northeastern Argentina IM Baeck, P Mando, BM Virasoro, A Martinez, S Zarate, R Valentini, ... The American Journal of Tropical Medicine and Hygiene 107 (1), 146, 2022 | 1 | 2022 |
